docetaxel anhydrous has been researched along with Cystitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, J; Li, J; Li, Y; Liu, N; Song, Y; Tang, X; Wu, Y; Xian, P; Xiong, L; Zhou, H | 1 |
1 other study(ies) available for docetaxel anhydrous and Cystitis
| Article | Year |
|---|---|
Efficacy and safety of Prostate stereotactic body radiotherapy for metastatic castration-resistant prostate cancer: A prospective cohort study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cystitis; Docetaxel; Dose Fractionation, Radiation; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Male; Neoplasm Grading; Orchiectomy; Proctitis; Progression-Free Survival; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiation Injuries; Radiosurgery; Random Allocation; Survival Rate; Tumor Burden | 2021 |